Burden of smoking on disease-specific mortality, DALYs, costs: the case of a high-income European country
- PMID: 37060054
- PMCID: PMC10103371
- DOI: 10.1186/s12889-023-15535-9
Burden of smoking on disease-specific mortality, DALYs, costs: the case of a high-income European country
Abstract
Background: Smoking is a major risk factor for chronic diseases causing early death and disability. Smoking prevalence over the past 25years has remained high in Switzerland. Evidence about the burden of disease and cost of illness attributable to smoking can support tobacco control. The aim of the present paper is to quantify from a societal perspective the mortality, disability-adjusted life years (DALYs), medical costs and productivity losses attributable to smoking in Switzerland in 2017.
Methods: Smoking attributable fractions (SAFs) were calculated based on the prevalence of current and former active smoking in the latest Swiss Health Survey from 2017 and relative risks from the literature. The SAFs were then multiplied with the number of deaths, DALYs, medical costs and productivity losses in the total population.
Results: In the Swiss population in 2017 smoking accounted for 14.4% of all deaths, for 29.2% of the deaths due to smoking-related diseases, 36.0% of the DALYs, 27.8% of the medical costs and 27.9% of productivity losses. Total costs amounted to CHF 5.0 billion which equals CHF 604 per capita per year. The highest disease burden in terms of mortality and DALYs attributable to smoking was observed for lung cancer and chronic obstructive pulmonary disease (COPD), whereas the highest cost of illness in terms of medical costs was observed for coronary heart diseases and lung cancer and in terms of productivity losses for COPD and coronary heart diseases. Sex and age group differences were found.
Conclusions: We provide an estimate of the burden of smoking on disease-specific mortality, DALYs, medical costs and productivity losses in Switzerland that could be prevented through evidence-based tobacco prevention and control policies as well as regular monitoring of tobacco consumption.
Keywords: Burden of disease; Chronic disease; Cost of illness; Smoking.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990-2019.Environ Sci Pollut Res Int. 2022 Feb;29(6):9293-9305. doi: 10.1007/s11356-021-16233-y. Epub 2021 Sep 9. Environ Sci Pollut Res Int. 2022. PMID: 34505240
-
Physical inactivity caused economic burden depends on regional cultural differences.Scand J Med Sci Sports. 2019 Jan;29(1):95-104. doi: 10.1111/sms.13311. Epub 2018 Oct 15. Scand J Med Sci Sports. 2019. PMID: 30260508
-
Projecting Long-term Health and Economic Burden of COPD in the United States.Chest. 2021 Apr;159(4):1400-1410. doi: 10.1016/j.chest.2020.09.255. Epub 2020 Oct 2. Chest. 2021. PMID: 33011203
-
Smoking-related diseases: the importance of COPD.Int J Tuberc Lung Dis. 2004 Dec;8(12):1423-8. Int J Tuberc Lung Dis. 2004. PMID: 15636487 Review.
-
The burden of disease and the cost of illness attributable to child maltreatment in Japan: long-term health consequences largely matter.BMC Public Health. 2020 Aug 27;20(1):1296. doi: 10.1186/s12889-020-09397-8. BMC Public Health. 2020. PMID: 32854682 Free PMC article. Review.
Cited by
-
Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients.Int J Chron Obstruct Pulmon Dis. 2024 Dec 9;19:2671-2688. doi: 10.2147/COPD.S484664. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39677832 Free PMC article.
-
Effectiveness of nurse-initiated smoking cessation intervention: a systematic review and meta-analysis.Subst Abuse Treat Prev Policy. 2025 Apr 7;20(1):18. doi: 10.1186/s13011-025-00648-8. Subst Abuse Treat Prev Policy. 2025. PMID: 40197534 Free PMC article.
-
Analysis of the direct economic impact of smoking-related hospitalizations in Italy.Tob Induc Dis. 2024 Jun 3;22. doi: 10.18332/tid/188111. eCollection 2024. Tob Induc Dis. 2024. PMID: 38832050 Free PMC article.
-
Challenges of smoking cessation in users of non-invasive stimulation technologies in Iran: a parallel convergent mixed-methods study.BMJ Open. 2024 Dec 26;14(12):e091253. doi: 10.1136/bmjopen-2024-091253. BMJ Open. 2024. PMID: 39725436 Free PMC article.
-
Alcohol and Periodontal Disease: A Narrative Review.Cureus. 2024 Jun 12;16(6):e62270. doi: 10.7759/cureus.62270. eCollection 2024 Jun. Cureus. 2024. PMID: 39006719 Free PMC article. Review.
References
-
- GBD 2015 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of Disease Study 2015. The Lancet. 2016;388(10053):1659–724. doi: 10.1016/S0140-6736(16)31679-8. - DOI - PMC - PubMed
-
- World Health Organization. WHO report on the global tobacco epidemic 2019: Offer help to quit tobacco use. 2019.
-
- Swiss Health Survey [Internet].Federal Statistical Office. 2017.
-
- World Health Organization. WHO report on the global tobacco epidemic, 2017 - Country Profile Switzerland. 2017.
-
- World Health Organization. WHO report on the global tobacco epidemic, 2015- raising taxes on tobacco. Geneva; 2015.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous